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The  Penn  State  Worry  Questionnaire  (PSWQ)  is  a widely  used  measure  of  worry  severity.  An  8-item
abbreviated  version  (PSWQ-A)  has  been  developed  as  a brief  screening  measure,  although  there  are
limited  studies  assessing  the  psychometric  properties  of this  measure  in  a large  geriatric  population.
The  aim  of  this  study  was  to assess  the  utility  of  the  PSWQ-A  compared  to  the full PSWQ,  to identify
pathological  worry  in  an  older  adult  sample  (N = 108)  of clinically  anxious  and  depressed  older  adults,
compared  to a non-clinical  sample  (N = 53).  The  PSWQ  and  PSWQ-A  were  found  to have  similarly  adequate
reliability  and  validity.  The  factor  structure  of  the  PSWQ-A  was  replicated,  but  not for the PSWQ.  BothSWQ-A
enn State Worry Questionnaire
bbreviated
eriatric
lder adult
orry
measures  accurately  distinguished  between  clinical  and  non-clinical  status  with  similar  sensitivity  and
speciﬁcity.  These  ﬁndings  indicate  the  PSWQ-A  is  a useful  measure  for screening  or epidemiological
studies  assessing  worry  in geriatric  populations.
©  2014  The  Authors.  Published  by  Elsevier  Ltd. This  is an  open  access  article  under  the CC  BY-NC-ND
license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).eneralized Anxiety Disorder
. Introduction
Generalized Anxiety Disorder (GAD) is the most common anxi-
ty disorder among treatment-seeking older adults (Beekman et al.,
998; Flint, 1994; Kessler et al., 2005; Wolitzky-Taylor, Castriotta,
enze, Stanley, & Craske, 2010) and its core feature, worry is com-
only reported among older populations (Beekman et al., 1998;
lint, 1994) as well as across a range of anxiety and mood disorders
McEvoy, Watson, Watkins, & Nathan, 2013; Kertz, Bigda-Peyton,
osmarin, & Bjorgvinsson, 2012). Left untreated, geriatric anxiety
s associated with increased functional and cognitive impairments,
ealth care use, psychological distress and mortality (Beaudreau
 O’Hara, 2008; Brenes et al., 2005; De Beurs et al., 1999; Nabi
t al., 2010; Wetherell et al., 2004). As such, it is important for
rimary, secondary and tertiary health care providers to be able
o reliably and validly measure worry as a basic, transdiagnostic
haracteristic of mental health problems in geriatric populations
uickly and easily. The Penn State Worry Questionnaire (PSWQ;
eyer, Miller, Metzger, & Borkovec, 1990) is a widely used 16-
tem measure of worry severity, including ﬁve reverse scored
tems. The PSWQ has been shown to have adequate psychometric
∗ Corresponding author. Tel.: +61 29850 4866; fax: +61 29850 8062.
E-mail address: Viviana.Wuthrich@mq.edu.au (V.M. Wuthrich).
ttp://dx.doi.org/10.1016/j.janxdis.2014.07.005
887-6185/© 2014 The Authors. Published by Elsevier Ltd. This is an open access article unproperties in younger samples, although there have been some
concerns regarding the factor structure and usability with older
adult samples. An abbreviated 8-item version of this measure has
been developed (PSWQ-A; Hopko et al., 2003). The PSWQ-A shows
promise as a useful brief screening measure that could be incorpo-
rated into routine screening of older adults in a variety of settings,
or used for epidemiological research, although research validating
the psychometric properties of this brief version with older adults
is still emerging in large geriatric samples.
The full PSWQ, is one of the most commonly used measures of
worry severity and has shown robust psychometric properties in
student samples (Hazlett-Stevens, Ullman, & Craske, 2004; Meyer
et al., 1990), non-clinical young adult samples (Knight, McMahon,
Skeaff, & Green, 2008), and clinical young adult samples (Brown,
Antony, & Barlow, 1992; Webb et al., 2008). In older adult samples,
the PSWQ has also shown good internal consistency (alpha = .83;
Stanley, Novy, Bourland, Beck, & Averill, 2001) and moderate con-
vergent validity with other measures of anxiety (Crittendon &
Hopko, 2006; Hopko et al., 2003). However, divergent validity from
measures of depression in clinical samples of older adults are vari-
able (Crittendon & Hopko, 2006; Hopko et al., 2003; Knight et al.,
2008; Stanley et al., 2001), and it has been shown to have modest
test–retest reliability over ten weeks, r = .54 (Stanley et al., 2001).
A cut-off score of 50 on the PSWQ has been shown to accurately
discriminate GAD from non-clinical samples with 82% sensitivity
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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nd 90% speciﬁcity (Stanley et al., 2003), and from other psychi-
tric disorders with 78% sensitivity and 70% speciﬁcity (Webb et al.,
008).
Interestingly, one of the main differences between the proper-
ies of the PSWQ in older and younger samples is reﬂected in its
actor structure. In younger samples, most research has demon-
trated a single factor across student, community and clinical
amples (Brown et al., 1992; Crittendon & Hopko, 2006; Knight
t al., 2008; van Rijsoort, Emmelkamp, & Vervaeke, 1999), although
ne study using a student sample suggested a two  factor solution
Fresco, Heimberg, Mennin, & Turk, 2002). This two factor solution
s also commonly found with older adult samples (Beck, Stanley,
 Zebb, 1995; Hopko et al., 2003). Interestingly, in the older adult
amples, the second factor tends to be comprised predominantly of
he reverse scored items of the PSWQ suggesting that its use may
ot be appropriate in older adults due to challenges responding to
egatively worded items.
In order to improve the psychometric properties and factor
tructure of the PSWQ in older adults, Hopko et al. (2003) developed
n abbreviated 8-item version (PSWQ-A) in an older GAD sam-
le in which the reverse scored items, as well as some unreliable
tems were eliminated. This abbreviated version shows promise
or use as a brief screening measure; however, studies of the psy-
hometrics of this measure with older adults are still emerging. So
ar, the abbreviated version has been shown in both older adult
ommunity, and older GAD patients, to have acceptable test–retest
eliability over 2–6 weeks (r = .63–.95), good discriminant validity
o distinguish patients with GAD from other anxiety disorders, and
onvergent validity against other measures of anxiety (Crittendon
 Hopko, 2006; Hopko et al., 2003; Knight et al., 2008; Stanley et al.,
003). Similar to the full PSWQ, evidence for the divergent validity
f the PSWQ-A from measures of depression in older adults is less
onsistent with excellent divergent validity in a sample of older
dults with GAD (Hopko et al., 2003) but poorer divergent validity
n a community dwelling older adult sample (Crittendon & Hopko,
006). The factor structure of the PSWQ-A has been demonstrated
o have a one-factor solution in both younger and older non-clinical
amples (Crittendon & Hopko, 2006; Knight et al., 2008) and in an
lder clinical sample with primary GAD (Hopko et al., 2003). More
esearch is needed to conﬁrm these ﬁndings in larger clinical and
on-clinical samples of older adults.
Finally, the PSWQ-A has also been shown to be useful for iden-
ifying clinical levels of anxiety in older adult samples. A cut-off
core of 23, was shown to be able to identify GAD in older adults
ompared to non-clinical older adults, with 82% speciﬁcity and
0% sensitivity (Stanley et al., 2011). Further, in older participants
ith anxiety disorders, the PSWQ-A has been shown to distinguish
he presence of GAD from those without GAD with 79% sensitivity
nd 63% speciﬁcity, with slightly improved accuracy among those
ithout comorbid depressive symptoms (Webb et al., 2008). One
tudy comparing the PSWQ and PSWQ-A in older adults has sug-
ested similar accuracy of the two measures to identify those with
AD from those without GAD (e.g., Webb et al., 2008). Therefore,
he PSWQ-A appears to be promising as a screening measure for
athological worry in older adult samples.
However, to date, all studies examining the ability of the PSWQ-
 to identify the presence of anxiety disorders have focused on
he identiﬁcation of GAD rather than an anxiety disorder more
roadly (Stanley et al., 2003; Webb et al., 2008). Further, one of
hese studies (Stanley et al., 2003) utilized a relatively small sam-
le size (GAD sample = 22 and comparison group = 10). Thus, an
xamination of the potential of the PSWQ-A as a screening mea-
ure for worry more generally across anxiety and mood disorders
n large geriatric clinical and non-clinical samples is missing. Also
iven the high comorbidity between anxiety and depression in
lder adults (Beekman et al., 2000; De Beurs et al., 1999), therey Disorders 28 (2014) 657–663
is limited research using the PSWQ-A as a screening measure for
anxiety in a sample with comorbid depression, and more research
in this area is needed.
This study sought to examine the utility of the PSWQ-A as a
screening measure in a large older sample of clinically anxious and
depressed older adults, and non-anxious and non-depressed older
adults, and to compare the psychometric properties of this measure
to the full PSWQ. We examined the factor structure of the two  meas-
ures, convergent and divergent validity against geriatric measures
of anxiety and depression, and examined the ability of these meas-
ures to discriminate the clinical group with comorbid anxiety and
depression from the non-clinical sample. We also examined the dif-
ferences in the ability of the PSWQ to distinguish older adults with
primary anxiety disorder, and also primary GAD to the non-clinical
sample.
2. Method
2.1. Participants
There was  a total of 161 participants (103 female, age
range = 60–86 years, M = 67.38, SD = 5.81) comprising two groups.
The clinical sample (N = 108, female = 64, age range = 60–85,
M = 67.33, SD = 5.76) were drawn from two randomized controlled
trials for the treatment of anxiety and depression in older adults
(Wuthrich & Rapee, 2013; Wuthrich, Rapee, Kangas, & Perini, 2014).
Participants were recruited through advertisements in local papers
seeking volunteers with worry, anxiety and low mood to partici-
pate in a treatment trial. Participants were included in this current
study if they had both a DSM-IV (American Psychiatric Association,
2000) anxiety and unipolar mood disorder. Diagnosis was deter-
mined through use of the Anxiety Disorders Interview Schedule
for DSM-IV (ADIS-IV; Di Nardo, Brown, & Barlow, 1994). Partici-
pants were excluded if they reported current self-harm or suicidal
ideation, psychosis or bipolar disorder.
In the clinical sample, 61 participants had a primary anxiety
disorder: Generalized Anxiety Disorder (34.5%), followed by Social
Phobia (8.2%), Anxiety Disorder Not Otherwise Speciﬁed (7.3%),
Post-Traumatic Stress Disorder (3.6%), Speciﬁc Phobia (1.8%) and
Agoraphobia without Panic Disorder (1%), along with a secondary
unipolar mood disorder. The remaining 47 participants had a pri-
mary unipolar mood disorder: Major Depressive Disorder (21.8%),
Dysthymia (11.8%), Depressive Disorder Not Otherwise Speciﬁed
(10%) along with a secondary anxiety disorder. Demographic char-
acteristics are shown in Table 1.
The non-clinical sample (N = 53, female = 39, age range = 60–86
years, M = 67.49, SD = 6.08) came from a previous study on cognitive
ﬂexibility (Johnco, Wuthrich, & Rapee, 2013) and were recruited
from advertisements in local newspapers seeking “happy healthy
older adult volunteers”. Participants were screened via telephone
using the screening questions from the ADIS, and excluded if they
reported experiencing anxiety, depression or any other mental
health condition to a clinically signiﬁcant degree. Participants’
scores on the self-report measures of anxiety and depression all
fell in the normal range (see Table 2).
2.2. Measures
Anxiety Disorders Interview Schedule (ADIS-IV; Di Nardo et al.,
1994) is a semi-structured interview for diagnosing anxiety and
related disorders according to DSM-IV criteria. Interviews were
administered by post-graduate clinical psychology students who
received training in its administration and had regular supervi-
sion. The interview assists clinicians to ascertain the presence and
severity of disorders using a rating scale of 0–8, where ratings of
V.M. Wuthrich et al. / Journal of Anxiety Disorders 28 (2014) 657–663 659
Table  1
Demographic data comparing clinical to non-clinical samples.
Non-clinical Clinical Chi-square/F Sig.
Age  M (SD)
67.49 (6.082) (%)
M (SD)
67.32 (5.76) (%)
.029 .867
Female 74 59 3.166 .083
Marital status 2.903 .715
Never  married 3.8 3.7
Married 52.8 50
De Facto 3.8 3.7
Separated 0 3.7
Divorced 22.6 26.8
Widowed 17.0 12.0
Country born 5.854 .440
Australia 69.8 69.4
England 15.1 6.48
New Zealand 0 1.85
Other 15.1 22.2
Highest qualiﬁcation 5.767 .330
Primary school 0 1.9
Secondary school 22.6 20.37
Certiﬁcate/trade certiﬁcate 13.2 19.44
Diploma 15.1 25
Bachelors degree 32.1 21.3
Postgraduate degree 17.0 12.04
Employment status 8.813 .184
Employed full time 5.7 7.41
Employed part-time 37.7 23.1
Retired 49.1 60.2
Full time home duties 3.8 4.6
Unable to work due to illness//injury 0 2.8
Gross income (Australian $) 11.923 1.55
<$15,599 (%) 17.0 20.4
$15,600–25,999 (%) 17.0 19.4
$26,000–41,599 (%) 18.9 20.4
$41,600–62,399 (%) 18.9 18.5
$62,400–83,999 (%) 9.4 12.0
4
i
(
t
(
a
1
s
c
r
o
e
8
c
t
T
D
N
V>$84,000 13.2 
Not willing to answer 5.7 
Receiving a seniors pension 41.5 
 and above are considered of clinical severity. Only participants
n the clinical sample completed the ADIS. Inter-rater reliability
k) for agreement on the presence of a disorder in the diagnos-
ic proﬁle was  k = 1.0 (100% agreement) for mood disorder, k = 1.0
100% agreement) for Generalized Anxiety Disorder and k = .81 (92%
greement) for social phobia.
Penn State Worry Questionnaire (PSWQ; Meyer et al., 1990) is a
6 item measure of worry that has shown adequate internal con-
istency and convergent validity in elderly patients with GAD and
ontrols (Beck et al., 1995; Stanley et al., 2001). However, some
esearch suggests that the test–retest reliability (over ten weeks) is
nly moderate in older adult samples, r = 54 (Stanley et al., 2001).
Penn State Worry Questionnaire – Abbreviated (PSWQ-A; Hopkot al., 2003) is an abbreviated version of the PSWQ which contains
 of the original items. The PSWQ-A has been shown to be highly
orrelated with the original measure, have good internal consis-
ency, and convergent validity in older adult samples (Hopko et al.,
able 2
escriptive statistics for self-report measures for the clinical and non-clinical samples.
Non-clinical
Sample (n = 53)
Range Mean (SD) 
PSWQ 18–35 32.89 (9.17) 
PSWQ-A 8–14 13.49 (5.40) 
GAI 0–0 .60 (1.38) 
GDS 0–1 2.37 (2.93) 
ote: GAI, Geriatric Anxiety Inventory; GDS, Geriatric Depression Scale; PSWQ, Penn Sta
ersion; SD, standard deviation.
** p < .001.8.3
0
69.4 .870 .351
2003). Although the test–retest reliability was  still only moderate
in the original sample, r = 63 (Hopko et al., 2003), it has been shown
to be high in other older adult samples over 2 and 6weeks, r = .92
and .95 respectively (Crittendon & Hopko, 2006). In this study the
scores for the PSWQ-A were extracted from the full version of the
PSWQ (as done by Hopko et al., 2003) rather than both versions
being administered separately.
Geriatric Depression Scale (GDS; Yesavage et al., 1983) is a 30
item self-report measure to determine the severity of depressive
symptoms in older adults. It has high internal consistency, reli-
ability, sensitivity and speciﬁcity (Jongenelis et al., 2005; Kieffer &
Reese, 2002; Yesavage et al., 1983). In this sample, internal reliabil-
ity was  good for the total sample (alpha = .94), non-clinical sample
(alpha = 79) and for the clinical sample (alpha = .82).
Geriatric Anxiety Inventory (GAI; Pachana et al., 2007) is a 20
item measure of anxiety symptom severity developed for older
adults. It has been shown to have adequate internal consistency,
Total clinical
Sample (n = 108)
F-value
Range Mean (SD)
28–59 53.23 (11.88) 121.65**
12–35 25.20 (7.89) 98.27**
2–16 10.45 (5.08) 191.67**
22–23 7.21 (6.28) 311.35**
te Worry Questionnaire; PSWQ-A, Penn State Worry Questionnaire – Abbreviated
660 V.M. Wuthrich et al. / Journal of Anxiet
Table  3
Correlations between self-report measures.
PSWQ PSWQ-A GDS
Total sample
GAI .819** .792** .798**
GDS .687** .683**
Clinical sample
GAI .700** .664** .488**
GDS .295* .345**
Non-clinical sample
GAI .564** .603** .666**
GDS .505** .489**
Note: GAI, Geriatric Anxiety Inventory; GDS, Geriatric Depression Scale; PSWQ, Penn
State Worry Questionnaire; PSWQ-A, Penn State Worry Questionnaire – Abbrevi-
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whether it was  sensitive to distinguishing primary GAD from non-
clinical status. Although all participants had both a mood and
anxiety disorder (with either being primary), we  examined the ROCted.
* p ≤ .05.
** p < .001.
est–retest reliability and concurrent validity (Pachana et al., 2007).
n this sample, internal consistency was good for the total sample
alpha = .94), non-clinical sample (alpha = 73) and clinical sample
alpha = .88).
.3. Procedure
Ethics approval for all studies was gained from the Macquarie
niversity Human Research Ethics Committee. All participants
ave informed written consent to participate. Non-clinical partic-
pants completed the measures as part of another study (Johnco,
uthrich, & Rapee, 2013). Clinical participants completed the
easures as part of the initial assessment (prior to treatment) as
art of two treatment studies (Wuthrich & Rapee, 2013; Wuthrich,
apee, Kangas, & Perini, 2014). A subsample (n = 22) completed the
SWQ and PSWQ-A again after receiving no treatment for 12 weeks.
nalyses were conducted using SPSS (Version 17) and STATA (Ver-
ion 12.1).
. Results
No signiﬁcant differences were found between the non-clinical
nd clinical samples in regards to demographic characteristics (see
able 1). Means and standard deviations on the PSWQ, PSWQ-A,
AI, and GDS for each of the samples can be seen in Table 2. All
ssumptions of normality were met. One-way ANOVAs comparing
he samples indicated that the clinical sample scored signiﬁcantly
igher on all measures than the non-clinical sample (see Table 2).
he means and standard deviations of the PSWQ and PSWQ-A are
imilar to those reported in other studies.
The full PSWQ showed good internal consistency in the non-
linical sample (alpha = .87), clinical sample (alpha = .89) and total
ample (alpha = .93). Given the PSWQ-A was extracted from the full
SWQ scale, it was unsurprising that there was a strong correlation
etween the two scales in the total, clinical and non-clinical sam-
les (r = .950, .941, and .846 respectively). Correlations between the
SWQ and the geriatric measures of anxiety (GAI) and depression
GDS) are presented in Table 3. The PSWQ demonstrated a strong
elationship with the GAI in the total and clinical samples, and a
oderate relationship in the non-clinical sample. The PSWQ also
orrelated strongly with the GDS in the total sample and moder-
tely in the clinical and the non-clinical samples. Steiger’s z-score
omparisons (Lee & Preacher, 2013) indicated that the correla-
ion between the PSWQ and GAI was signiﬁcantly stronger than
he correlation between the PSWQ and GDS in the total (z = 4.342,
 < .001) and clinical samples (z = 5.152, p < .001), but not the non-
linical sample (z = .626, p = .531). The results were similar for the
SWQ-A, with good internal consistency found in the non-clinical,
linical and total samples (alpha = .87, .91 and .94 respectively).
orrelations between the PSWQ-A and the GAI and GDS arey Disorders 28 (2014) 657–663
reported in Table 3 and demonstrate that the PSWQ-A was moder-
ately correlated with the GAI and GDS in all samples. Comparisons
indicated that the correlation between the PSWQ-A and GAI  was
signiﬁcantly stronger than the correlation between the PSWQ-
A and GDS in the total (z = 3.423, p < .001) and clinical samples
(z = 3.982, p < .001), but not the non-clinical sample (z = 1.230,
p = .219).
Test–retest reliability was  examined using a subset of the clin-
ical sample (n = 22) who  were required to have no intervention
for 12 weeks as part of the treatment trial (Wuthrich & Rapee,
2013). Adequate test–retest reliability was  found for both the PSWQ
(r = 74) and the PSWQ-A (r = .70) over a 12-week period.
Factor structure was tested with conﬁrmatory factor analy-
sis using the Analysis Moments of Structure program version 5
(Arbuckle, 1983–2010). Models were analyzed using the variance-
covariance matrix. The ﬁt of the models was  tested by modeling
the ﬁt of the PSWQ onto both one and two  factors for the PSWQ
and one factor for the PSWQ-A separately. Maximum likelihood
estimation was used and model signiﬁcance was determined using
the chi-square statistic, Bentler’s (1990) CFI, Tucker Lewis Index
(TLI: Tucker & Lewis, 1973), and Steiger’s RSMEA (Steiger & Lind,
1980). The cutoff value for model signiﬁcance was  set at .95 for CFI
and TLI, and .08 for RSMEA, and RSMEA was reported with a 90%
conﬁdence interval (CI). The one factor model for the PSWQ,  2
(104, N = 161) = 365.81, p ≤ .001), had a poor ﬁt (CFI = .861, TLI = .818,
RSMEA = .125, 90% CI = .112–.140, AIC = 461.814). The two factor
model for the PSWQ, 2 (103, N = 161) = 229.770, p = <.001, as
described by Hopko et al. (2003) in which the reverse scored items
formed a second factor, also resulted in an inadequate ﬁt (CFI = .933,
TLI = .911, RSMEA = .088, 90% CI = .073–.103, AIC = 327.770). This
replicated Hopko et al.’s own  results showing an inadequate ﬁt of
the two factor structure of the PSWQ in older adults and prompted
the development of the PSWQ-A. Finally we  tested the ﬁt of a one
factor model of the PSWQ-A, 2 (20, N = 161) = 31.50, p = 05,1 and
found that it produced a good ﬁt on all indices (CFI = .99, TLI = .98,
RSMEA = .06, 90% CI = .004–.098, AIC = 79.503).
Finally, we  conducted a receiver operating characteristics (ROC)
analysis in STATA Version 12. 1 (StataCorp., 2011) to determine the
speciﬁcity and sensitivity of the PSWQ and PSWQ-A to correctly
identify clinical disorder vs non-clinical status in the two samples
(see Fig. 1). The accuracy of a diagnostic test is evaluated by the area
under the ROC curve, with an area of 1 representing a perfect test
and an area of .5 representing an inadequate test. The area under
the curve for the PSWQ was .91 (SE = .02, p < .001; 95% CI = .86–.96),
and for the PSWQ-A was  .89 (SE = .03, p < .001, 95% CI = .82–.94)
indicating that, based on a cut off of 50, the PSWQ could correctly
identify clinical status with 61.5% sensitivity and 94.3% speciﬁcity,
while a cut-off score of 23 on the PSWQ-A could correctly iden-
tify clinical status with 66.4% sensitivity and 92.5% speciﬁcity.
There was a signiﬁcant difference between these two  curves, 2
(1) = 4.1, p = <.05, indicating that the PSWQ was signiﬁcantly better
at detecting clinical status. Kappa coefﬁcients estimating relative
agreement between clinical and community status are presented in
Table 4, and indicate 48% agreement for PSWQ and 51% agreement
for PSWQ-A.
Given the PSWQ is a measure of worry, we also examined
whether it was more sensitive to identifying primary anxiety dis-
order status rather than a primary anxiety or mood disorder, and1 The chi-square test (2) indicates the amount of difference between expected
and  observed covariance matrices. Therefore a non-signiﬁcant chi-square statistic
is  desirable.
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Aig. 1. Receiver operating characteristic analysis for the PSWQ and PSWQ-A using
he clinical and non-clinical sample. Note: PSWQ, Penn State Worry Questionnaire;
SWQ-A, Penn State Worry Questionnaire – Abbreviated.
urves for the 61 participants in the sample with a primary anx-
ety disorder, and the 37 participants with primary GAD, to the
on-clinical sample. Overall the results indicated that the PSWQ
nd PSWQ-A were able to identify those with primary anxiety dis-
rder, and those with primary GAD, from the community sample
ell. The ROC results indicated that the PSWQ could accurately
dentify clinical status (based on a cut off of 50) in the primary anx-
ety sample with 71.7% sensitivity and 99.9% speciﬁcity, ROC = .94,
E = .02, 95% CI = .89–.98. In addition, the PSWQ-A (based on a cut
ff of 23) could identify primary anxiety disorder with 77.0% sensi-
ivity and 92.5% speciﬁcity, ROC = .91, SE = .03, 95% CI = .85–.96. The
ifference between the two ROC analyses was not signiﬁcant, 2
1) = 3.3, p = 07, indicating little difference between the PSWQ and
SWQ-A in identifying those with a primary anxiety disorder (see
ig. 2). Kappa coefﬁcients estimating relative agreement between
DIS diagnoses and the PSWQ and PSWQ-A cases based on cut-
ff scores are presented in Table 4 and indicate 65% agreement
or PSWQ and 69% agreement for PSWQ-A. Similarly, the PSWQ
ccurately identiﬁed primary GAD status compared to non-clinical
ample (sensitivity 72.2%, speciﬁcity 94.3%, Kappa = .69, ROC = .95,
E = .02, 95% CI = .91–.99) as did the PSWQ-A (sensitivity 75.7%,
peciﬁcity 92.5%, Kappa .70, ROC = .91, SE = .03, 95% CI = .86–.97).
he difference between the two ROC analyses for identifying pri-
ary GAD was signiﬁcant, 2 (1) = 4.05, p < 05, indicating the PSWQ
as signiﬁcantly better at detecting the presence of primary GAD
ompared to the PSWQ-A.. Discussion
This study examined the psychometric characteristics of the
SWQ and PSWQ-A, in a clinical geriatric sample with comorbid
able 4
ensitivity, Speciﬁcity and Kappa values for the PSWQ and PSWQ-A.
Sample Measure AUC (SE
Total clinical vs non-clinical
(n = 161)
PSWQ .91 
PSWQ-A .89 
Primary anxiety disorder vs
non-clinical (n = 114)
PSWQ .94 
PSWQ-A .91 
Primary GAD vs non-clinical (n = 90) PSWQ .95 
PSWQ-A 93( .03
ote: AUC, Area under the curve; PSWQ, Penn State Worry Questionnaire; PSWQ-A, Pen
nxiety Disorder.
** p < 001.Fig. 2. Receiver operating characteristic analysis for the PSWQ and PSWQ-A using
the primary anxiety disorder and non-clinical sample. Note: PSWQ, Penn State Worry
Questionnaire; PSWQ-A, Penn State Worry Questionnaire – Abbreviated.
anxiety and mood disorders and a non-clinical sample to establish
the utility of the PSWQ-A as a screening measure for pathologi-
cal worry and for the presence of GAD in older adults. The results
demonstrated adequate internal consistency of both the PSWQ
and PSWQ-A in older adult non-clinical and clinical samples, along
with good test–retest reliability of the PSWQ and PSWQ-A over a
12-week period, adding to the limited literature on test–retest reli-
ability. Our results found evidence of strong convergent validity
between both the PSWQ and PSWQ-A with the GAI, and mod-
erate relationships with the GDS mirroring previous ﬁndings in
geriatric community and clinically anxious samples (Crittendon
& Hopko, 2006; Hopko et al., 2003; Stanley et al., 2001). Results
suggested that the convergent validity was  stronger between the
PSWQ and a geriatric measure of anxiety (GAI) compared to the
relationship with a geriatric measure of depression (GDS) in the
total and clinical samples, although there was no difference in
this relationship in the non-clinical sample. The moderate over-
lap between the PSWQ and GDS was mirrored between the GAI
and GDS and is likely to reﬂect the overlapping constructs of anx-
iety and depression generally. Our results from the factor analyses
matched the failure by Hopko et al. (2003) to ﬁnd an adequate ﬁt
of either one or two factor models of the PSWQ in older adults,
suggesting a more problematic factor structure of the full scale
with older adults. However, our results did demonstrate a good
ﬁt of a one factor solution of the PSWQ-A in older adults, repli-
cating previous research (Crittendon & Hopko, 2006; Hopko et al.,
2003).In addition, we compared the ability of the PSWQ and PSWQ-A to
correctly categorize clinically anxious and depressed older adults
from non-clinical older adults, and to discriminate primary GAD
from the non-clinical sample. The results indicated that in the total
) Sensitivity Speciﬁcity Kappa
(.02) 61.5 94.3 .48**
(.03) 66.4 92.5 .51**
(.02) 71.7 99.9 .65**
(.03) 77.0 92.5 .69**
(.02) 72.2 94.3 .69**
) 75.7 92.5 .70**
n State Worry Questionnaire – Abbreviated; SE, standard error; GAD, Generalized
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ample, both the PSWQ and the PSWQ-A were able to distinguish
linical status with good sensitivity and speciﬁcity. The PSWQ-A
as found to accurately categorize primary anxiety disorder status
rom non-clinical status with good sensitivity (77.0%) and speci-
city (92.5%), and similarly primary GAD from non-clinical status
ith good sensitivity (75.7%) and speciﬁcity (92.5%). However, the
esults also indicated that the PSWQ and PSWQ could accurately
ategorize comorbid clinical anxiety and depression more generally
rom non-clinical status with 66.4% sensitivity and 92.5% speci-
city. These results ﬁt with the emerging research showing that
athological worry or negative thinking generally may  be a trans-
iagnostic construct that is associated with a range of anxiety and
ood disorders (Kertz et al., 2012; McEvoy et al., 2013). Therefore
he PSWQ and PSWQ-A can be used as measures sensitive to patho-
ogical worry or negative thinking more generally across anxiety
nd mood disorders as well as GAD, at least in older adult samples.
The ROC analysis indicated that the PSWQ explained signif-
cantly more variance under the curve than the PSWQ-A when
omparing clinical anxiety or depression with the non-clinical sam-
le, and when comparing primary GAD to the non-clinical sample,
lthough there was no signiﬁcant difference when comparing par-
icipants with primary anxiety disorder to the non-clinical sample.
lthough the full PSWQ was found to be signiﬁcantly better in two
f these comparisons, the sensitivity and speciﬁcity achieved by the
SWQ-A in these categorizations was still adequate and therefore
he PSWQ-A is useful as a screening measure.
Our results indicate the main difference between the PSWQ
nd PSWQ-A favored the factor structure in the PSWQ-A; how-
ver, the full PSWQ showed slightly superior ability to identify
hose with pathological worry. Given the good and compara-
le psychometric properties of the PSWQ-A compared to the
ull PSWQ, this brief measure is adequate and would likely be
seful for epidemiological or screening purposes. While pre-
ious studies have included a proportion of participants with
omorbid mood disorders, comorbidity is common in older adult
amples (Beaudreau & O’Hara, 2008; Beekman et al., 2000; De Beurs
t al., 1999) and the comparable psychometric performance of the
SWQ-A in our comorbid sample further supports the use of this
easure for identifying pathological worry in geriatric popula-
ions.
There are several limitations of this study that need to be consid-
red. Firstly, the scores for the PSWQ-A were derived from the full
ersion of the PSWQ (as previously done by Hopko et al., 2003) and
o comparisons between the measures needs to be interpreted with
aution. Crittendon and Hopko (2006) administered the PSWQ and
SWQ-A separately in their study, and they reported only a mod-
rate correlation between the two measures (r = .65), suggesting
otential variability in responses across the two different adminis-
rations or differences in what is measured in the two scales. This
ontrasts with our strong correlations between the two  measures
hen derived from the same administration (r = .85–.95). However,
y extracting the PSWQ-A in this way, it allowed direct comparison
etween the measures when interpreting ROC analyses as we are
ble to make conclusions about whether using only the abbrevi-
ted version is superior, without being confounded by variability
aused by having administered the two measures separately. Fur-
her, it is a limitation that the non-clinical sample did not receive
he full diagnostic interview. Therefore it is possible that some of
he non-clinical sample might have met  criteria for a clinical dis-
rder. Finally, given the signiﬁcant changes to the structure of the
isorder categories in DSM-5, these results apply to anxiety disor-
ers as listed in the DSM-5, but also Post-Traumatic Stress Disorder
PTSD) which is now classed in a new category. Although our sam-
le of participants with PTSD was small and so more research is
eeded in this disorder. Finally, although we did not exclude par-
icipants with Obsessive Compulsive Disorder (OCD), there werey Disorders 28 (2014) 657–663
no participants with OCD in our sample, and so more research is
needed in this class of disorders.
Overall our results indicated that the reliability and validity of
the PSWQ and PSWQ-A was  similar. The ability for the PSWQ and
PSWQ-A to identify clinical status and the presence of primary GAD
was similar, although slightly favored the PSWQ. Given the superior
factor structure of the PSWQ-A, and that this abbreviated version
closely mimics the psychometric properties of the full version, the
PSWQ-A shows promise as a good measure for screening or epi-
demiological purposes for identifying pathological worry across
anxiety and mood disorders in older adult samples.
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